Literature DB >> 23560645

Anti-infective therapy of peri-implantitis with adjunctive local drug delivery or photodynamic therapy: 12-month outcomes of a randomized controlled clinical trial.

Mario Bassetti1, Dorothee Schär1, Beat Wicki1, Sigrun Eick1, Christoph A Ramseier1, Nicole B Arweiler2, Anton Sculean1, Giovanni E Salvi1.   

Abstract

OBJECTIVE: The objective of the study is to compare the clinical, microbiological and host-derived effects in the non-surgical treatment of initial peri-implantitis with either adjunctive local drug delivery (LDD) or adjunctive photodynamic therapy (PDT) after 12 months.
MATERIALS AND METHODS: Forty subjects with initial peri-implantitis, that is, pocket probing depths (PPD) 4-6 mm with bleeding on probing (BoP) and radiographic bone loss ≤2 mm, were randomly assigned to two treatment groups. All implants were mechanically debrided with titanium curettes and with a glycine-based powder airpolishing system. Implants in the test group (N = 20) received adjunctive PDT, whereas minocycline microspheres were locally delivered into the peri-implant pockets of control implants (N = 20). At sites with residual BoP, treatment was repeated after 3, 6, 9 and 12 months. The primary outcome variable was the change in the number of peri-implant sites with BoP. Secondary outcome variables included changes in PPD, clinical attachment level (CAL), mucosal recession (REC) and in bacterial counts and crevicular fluid (CF) levels of host-derived biomarkers.
RESULTS: After 12 months, the number of BoP-positive sites decreased statistically significantly (P < 0.05) from baseline in both groups (PDT: 4.03 ± 1.66-1.74 ± 1.37, LDD: 4.41 ± 1.47-1.55 ± 1.26). A statistically significant (P < 0.05) decrease in PPD from baseline was observed at PDT-treated sites up to 9 months (4.19 ± 0.55 mm to 3.89 ± 0.68 mm) and up to 12 months at LDD-treated sites (4.39 ± 0.77 mm to 3.83 ± 0.85 mm). Counts of Porphyromonas gingivalis and Tannerella forsythia decreased statistically significantly (P < 0.05) from baseline to 6 months in the PDT and to 12 months in the LDD group, respectively. CF levels of IL-1β decreased statistically significantly (P < 0.05) from baseline to 12 months in both groups. No statistically significant differences (P > 0.05) were observed between groups after 12 months with respect to clinical, microbiological and host-derived parameters.
CONCLUSIONS: Non-surgical mechanical debridement with adjunctive PDT was equally effective in the reduction of mucosal inflammation as with adjunctive delivery of minocycline microspheres up to 12 months. Adjunctive PDT may represent an alternative approach to LDD in the non-surgical treatment of initial peri-implantitis.
© 2013 John Wiley & Sons A/S. Published by Blackwell Publishing Ltd.

Entities:  

Keywords:  clinical research; clinical trials; drug delivery; laser; microbiology; pharmacology; wound healing

Mesh:

Substances:

Year:  2013        PMID: 23560645     DOI: 10.1111/clr.12155

Source DB:  PubMed          Journal:  Clin Oral Implants Res        ISSN: 0905-7161            Impact factor:   5.977


  39 in total

1.  Surgical and non-surgical debridement for the treatment of peri-implantitis: a two-center 12-month randomized trial.

Authors:  Tassiane Panta Wagner; Paula Rodrigues Pires; Fernando Silva Rios; Joao Augusto Peixoto de Oliveira; Ricardo Dos Santos Araujo Costa; Kelly F Cunha; Heraldo Luis Dias Silveira; Suzana Pimentel; Marcio Zaffalon Casati; Cassiano Kuchenbecker Rosing; Alex Nogueira Haas
Journal:  Clin Oral Investig       Date:  2021-03-16       Impact factor: 3.573

Review 2.  [Progress on photodynamic therapy in oral diseases].

Authors:  Shen-Sui Li; Chen-Zhou Wu; Long-Jiang Li
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2021-04-01

3.  Vancomycin and tobramycin impregnated mineralized allograft for the surgical regenerative treatment of peri-implantitis: a 1-year follow-up case series.

Authors:  José Nart; Beatriz de Tapia; Àngels Pujol; Andrés Pascual; Cristina Valles
Journal:  Clin Oral Investig       Date:  2017-12-24       Impact factor: 3.573

4.  Novel bioactive tetracycline-containing electrospun polymer fibers as a potential antibacterial dental implant coating.

Authors:  R G Shahi; M T P Albuquerque; E A Münchow; S B Blanchard; R L Gregory; M C Bottino
Journal:  Odontology       Date:  2016-09-01       Impact factor: 2.634

5.  Non-surgical therapeutic outcomes of peri-implantitis: 12-month results.

Authors:  José Nart; Ramón Pons; Cristina Valles; Alejandro Esmatges; Ignacio Sanz-Martín; Alberto Monje
Journal:  Clin Oral Investig       Date:  2019-05-23       Impact factor: 3.573

6.  Evaluation of Effectiveness of Photodynamic Therapy With Low-level Diode Laser in Nonsurgical Treatment of Peri-implantitis.

Authors:  Ehsan Birang; Mohammad Reza Talebi Ardekani; Mahboobeh Rajabzadeh; Gloria Sarmadi; Reza Birang; Norbert Gutknecht
Journal:  J Lasers Med Sci       Date:  2017-06-27

Review 7.  The Impact of Incorporating Antimicrobials into Implant Surfaces.

Authors:  N J Hickok; I M Shapiro; A F Chen
Journal:  J Dent Res       Date:  2017-09-18       Impact factor: 6.116

8.  Wound models for periodontal and bone regeneration: the role of biologic research.

Authors:  Anton Sculean; Iain L C Chapple; William V Giannobile
Journal:  Periodontol 2000       Date:  2015-06       Impact factor: 7.589

9.  Six-month results following treatment of aggressive periodontitis with antimicrobial photodynamic therapy or amoxicillin and metronidazole.

Authors:  Nicole Birgit Arweiler; Malgorzata Pietruska; Jan Pietruski; Ana Skurska; Eva Dolińska; Christian Heumann; Thorsten Mathias Auschill; Anton Sculean
Journal:  Clin Oral Investig       Date:  2014-02-04       Impact factor: 3.573

10.  Titanium as a modifier of the peri-implant microbiome structure.

Authors:  Diane Daubert; Alexander Pozhitkov; Jeffrey McLean; Georgios Kotsakis
Journal:  Clin Implant Dent Relat Res       Date:  2018-09-25       Impact factor: 3.932

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.